share_log

Maxim Group Initiates Coverage On Virios Therapeutics With Buy Rating, Announces Price Target of $1

Maxim Group Initiates Coverage On Virios Therapeutics With Buy Rating, Announces Price Target of $1

Maxim Group发起对Virios Therapeutics的买入评级,宣布目标价格为1美元。
Benzinga ·  06/20 07:47

Maxim Group analyst Jason McCarthy initiates coverage on Virios Therapeutics (NASDAQ:VIRI) with a Buy rating and announces Price Target of $1.

Maxim集团分析师杰森·麦卡锡以买入评级启动了对Virios Therapeutics(纳斯达克股票代码:VIRI)的报道,并宣布目标股价为1美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发